INSIGHTS ON DRUG DEVELOPMENT

• Drug Substance For Early Clinical Phase Initiation

  Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.

• Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques

  Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.

• Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™

  Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.

• AAV Downstream Challenges: Expert Insights

  Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.

• Streamline Drug Development With A Lab Informatics Platform

  8/13/2025

  Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.

• Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook

  12/11/2025

  View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.

• Temperature Dependence On Reversed-Phase Separations

  7/17/2025

  Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.

• Best Practices In Formulation And Lyophilization Development: Proteins, mAbs And ADCs

  10/16/2024

  Discover how advancements in pharmaceutical freeze-drying are reshaping the process through better product understanding, precise process control, and innovations in equipment efficiency.

• Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development

  6/19/2025

  Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.